Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Practical Guidance on Clinical Management of Belantamab Mafodotin‐Associated Ocular Events
Evangelos Terpos, Suzanne Trudel, María‐Victoria Mateos, Nicolás Alejandre, Kathryn Colby, Meletios A Dimopoulos, Simona Degli Esposti, Asim V. Farooq, Maria Gavriatopoulou, Francesca Gay, Vânia Hungria, K. Martin Kortüm, Xavier Leleu, Sagar Lonial, Hang Quach, Lugui Qiu, Karthik Ramasamy, Kazuhito Suzuki, Katja Weisel, Paul G. Richardson (2025). Practical Guidance on Clinical Management of Belantamab Mafodotin‐Associated Ocular Events. , 100(10), DOI: https://doi.org/10.1002/ajh.70015.
Article34 days agoP-137 A phase 3, two-stage, randomized study of iberdomide maintenance versus lenalidomide maintenance post autologous stem cell transplantation in newly diagnosed multiple myeloma: EXCALIBER-maintenance
Francesca Gay, Meletios A Dimopoulos, Xiao‐Jun Huang, Sagar Lonial, Karthik Ramasamy, Michael Amatangelo, A. Abouihia, Mark Masin, Hina Maniar, Jorge Acosta‐Reyes, Paulo Maciag, Niels W.C.J. van de Donk (2023). P-137 A phase 3, two-stage, randomized study of iberdomide maintenance versus lenalidomide maintenance post autologous stem cell transplantation in newly diagnosed multiple myeloma: EXCALIBER-maintenance. , 23, DOI: https://doi.org/10.1016/s2152-2650(23)01755-x.
Article33 days agoP-137 A phase 3, two-stage, randomized study of iberdomide maintenance versus lenalidomide maintenance post autologous stem cell transplantation in newly diagnosed multiple myeloma: EXCALIBER-maintenance
Francesca Gay, Meletios A Dimopoulos, Xiao‐Jun Huang, Sagar Lonial, Karthik Ramasamy, Michael Amatangelo, A. Abouihia, Mark Masin, Hina Maniar, Jorge Acosta‐Reyes, Paulo Maciag, Niels W.C.J. van de Donk (2023). P-137 A phase 3, two-stage, randomized study of iberdomide maintenance versus lenalidomide maintenance post autologous stem cell transplantation in newly diagnosed multiple myeloma: EXCALIBER-maintenance. , 23, DOI: https://doi.org/10.1016/s2152-2650(23)01755-x.
Article33 days agoOral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial
Meletios A Dimopoulos, Fredrik Schjesvold, Vadim Doronin, Olga Vinogradova, Hang Quach, Xavier Leleu, Yolanda González Montes, Karthik Ramasamy, Alessandra Pompa, Mark‐David Levin, Cindy Lee, Ulf Henrik Mellqvist, Roland Fenk, Hélène Demarquette, Hamdi Sati, Alexander Vorog, Richard Labotka, Jichang Du, Mohamed Darif, Shaji Kumar (2022). Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial. , 12(1), DOI: https://doi.org/10.1038/s41408-021-00593-2.
Article33 days agoManagement of Patients with Difficult-To-Treat Multiple Myeloma
Joshua Richter, Karthik Ramasamy, Leo Rasche, Joan Bladé, Sonja Zweegman, Faith E. Davies, Meletios A Dimopoulos (2021). Management of Patients with Difficult-To-Treat Multiple Myeloma. , 17(16), DOI: https://doi.org/10.2217/fon-2020-1280.
Article33 days ago